GKCC LLC 13D and 13G filings for MiNK Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-22 4:33 pm Purchase | 2024-05-14 | 13G | MiNK Therapeutics, Inc. INKT | GKCC LLC | 464,000 11.790% | 464,000 (New Position) | Filing |